EDITION:

Search
Search
Close this search box.

Quick Hits with Guy Chamberland, PhD, Chief Science Officer and Interim CEO, Tetra Bio-Pharma

Guy Chamberland, PhD, Chief Science Officer and Interim CEO of Tetra Bio-Pharma joined us for a Quick Hits conversation about medical cannabis, research, development and the future of the sector in Canada and worldwide.

Tetra Bio-Pharma is Orleans, Ontario-based biopharmaceutical company researching and developing cannabinoid-based drugs. They aim to bring novel drugs and treatments to patients and their healthcare providers.

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?